Microvesicles/exosomes as potential novel biomarkers of metabolic diseases
Günter MüllerDepartment of Biology 1, Genetics, Ludwig-Maximilians University Munich, Biocenter, Munich, GermanyAbstract: Biomarkers are of tremendous importance for the prediction, diagnosis, and observation of the therapeutic success of common complex multifactorial metab...
Enregistré dans:
Auteur principal: | Müller G |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2012
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/7f55c13c4cda4cb7b110d2d8103806c5 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Diet-induced metabolic hamster model of nonalcoholic fatty liver disease
par: Bhathena J, et autres
Publié: (2011) -
The association between obesity, cardiometabolic disease biomarkers, and innate immunity-related inflammation in Canadian adults
par: Da Costa LA, et autres
Publié: (2012) -
Metabolic abnormalities in pituitary adenoma patients: a novel therapeutic target and prognostic factor
par: Zheng X, et autres
Publié: (2015) -
Disturbance of inorganic phosphate metabolism in diabetes mellitus: temporary therapeutic intervention trials
par: Jørn Ditzel, et autres
Publié: (2009) -
Relationship between chronic kidney disease and metabolic syndrome: current perspectives
par: Nashar K, et autres
Publié: (2014)